New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neural Regeneration Research

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/1673-5374.202942PMID 28469653PMCID 5399716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders.

  2017cited by this paper
• Deep Eutectic Solvents as Novel and Effective Extraction Media for Quantitative Determination of Ochratoxin A in Wheat and Derived Products

  2017cited by this paper
• Plant Food Supplements with Antioxidant Properties for the Treatment of Chronic and Neurodegenerative Diseases: Benefits or Risks?

  2017cited by this paper
• Hydroxypyridinone Derivatives: A Fascinating Class of Chelators with Therapeutic Applications - An Update.

  2017cited by this paper
• Reduction of Aflatoxins in Apricot Kernels by Electronic and Manual Color Sorting

  2016cited by this paper
• Rutin as a Natural Therapy for Alzheimer's Disease: Insights into its Mechanisms of Action.

  2016cited by this paper
• Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy.

  2016influential reference
• Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175.

  2015cited by this paper
• On the Metabolically Active Form of Metaglidasen: Improved Synthesis and Investigation of Its Peculiar Activity on Peroxisome Proliferator‐Activated Receptors and Skeletal Muscles

  2015cited by this paper
• Food coloring agents and plant food supplements derived from Vitis vinifera: a new source of human exposure to ochratoxin A.

  2015cited by this paper
• Open tubular columns containing the immobilized ligand binding domain of peroxisome proliferator-activated receptors α and γ for dual agonists characterization by frontal affinity chromatography with mass spectrometry detection.

  2013cited by this paper
• Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors α/γ dual agonists.

  2012cited by this paper

• Application of mesenchymal stem cell-derived exosomes in the treatment of aging-related degenerative diseases

  2026cites this paper
• Modeling Temporal Dependencies and Feature Interactions Reveal Novel Clinical and Molecular Insights into Alzheimer’s Disease Progression

  2025cites this paper
• Role of copper chelating agents: between old applications and new perspectives in neuroscience

  2024cites this paper
• 1, 2, 3-triazole based conjugates-potential cholinesterase (AChE and BuChE) and BACE inhibitors for treatment of Alzheimer

  2023cites this paper
• Anti-Alzheimer’s Natural Products Derived from Plant Endophytic Fungi

  2023cites this paper
• Neuroprotective Effects and Mechanisms of Senegenin, an Effective Compound Originated From the Roots of Polygala Tenuifolia

  2022cites this paper
• Explainable AI toward understanding the performance of the top three TADPOLE Challenge methods in the forecast of Alzheimer’s disease diagnosis

  2022cites this paper
• Recent Advances in Nanomaterials for Diagnosis, Treatments, and Neurorestoration in Ischemic Stroke

  2022cites this paper
• Novel Donepezil–Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer’s Disease

  2021cites this paper
• Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration

  2021cites this paper
• Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents

  2021influential citation
• Amyloid-beta (Aβ1-42)-induced paralysis in Caenorhabditis elegans is reduced through NHR-49/PPARalpha.

  2020cites this paper
• Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2-Hydroxyphenylbenzimidazole-Based Scaffolds en Route to Donepezil-Like Compounds

  2020cites this paper
• A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders.

  2020cites this paper
• Polygala tenuifolia: a source for anti-Alzheimer’s disease drugs

  2020cites this paper
• Environmental Toxins and Alzheimer's Disease Progression.

  2020cites this paper
• Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents

  2020cites this paper
• Inhibition of BACE1, MAO-B, cholinesterase enzymes, and anti-amyloidogenic potential of selected natural phytoconstituents: Multi-target-directed ligand approach.

  2020cites this paper
• Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer’s disease

  2019cites this paper
• An innovative approach for the treatment of Alzheimer’s disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions

  2019influential citation
• "Shanghuo" increases disease susceptibility: Modern significance of an old TCM theory.

  2019cites this paper
• Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats

  2019cites this paper
• Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease

  2019cites this paper
• Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s drug candidates

  2018cites this paper
• Assessment of antioxidant, anticholinesterase and antiamyloidogenic effect of Terminalia chebula, Terminalia arjuna and its bioactive constituent 7-Methyl gallic acid – An in vitro and in silico studies

  2018cites this paper
• A cross-sectional study of serum Brain Derived Neurotropic Factor (BDNF) concentrations in a Saudi population and changes associated with the use of Selective Serotonin Reuptake Inhibitors (SSRIs) in patients with Alzheimer's disease

  2018cites this paper
• Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer’s Disease

  2018influential citation
• Nanomedicine and Phage Capsids

  2018cites this paper
• Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer’s disease therapy

  2017cites this paper
• Why does Finland have the highest dementia mortality rate? Environmental factors may be generalizable.

  2017cites this paper
• Inhibitory Effect of Lycopene on Amyloid-β-Induced Apoptosis in Neuronal Cells

  2017cites this paper
• The Role of Food Antioxidants, Benefits of Functional Foods, and Influence of Feeding Habits on the Health of the Older Person: An Overview

  2017cites this paper